RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @jebibault: After @piet_ost’s STOMP trial, further confirmation that SBRT is relevant in oligometastatic #ProstateCancer! Progression of…
☢️Intense form of radiation slows disease progression in some men with prostate #cancer From @JAMAOnc journal: ➡️https://t.co/T2QqdYQtcb https://t.co/b6laB4W4nq
RT @ErinGillespieMD: 54 pts with oligomet prostate ca (1-3 lesions: 2/3 node-only, 1/3 bone-only). "Total consolidation of PSMA radiotracer…
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
Good news in COVID times... PFS now...looking for freeADT,....OS?..combined TX?...Better times are arriving...
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
Os dejamos este ensayo clínico sobre cómo el uso de la radioterapia ablativa estereotáctica en el cáncer de próstata oligometastásico podría proporcionar, junto con otras terapias sistémicas,el ataque múltiple requerido para su cura. 📄Artículo aquí [EN] h
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @ErinGillespieMD: 54 pts with oligomet prostate ca (1-3 lesions: 2/3 node-only, 1/3 bone-only). "Total consolidation of PSMA radiotracer…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @jebibault: After @piet_ost’s STOMP trial, further confirmation that SBRT is relevant in oligometastatic #ProstateCancer! Progression of…
Promising results @TroussierIdriss https://t.co/EQ0wU49qAW
RT @jebibault: After @piet_ost’s STOMP trial, further confirmation that SBRT is relevant in oligometastatic #ProstateCancer! Progression of…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @jebibault: After @piet_ost’s STOMP trial, further confirmation that SBRT is relevant in oligometastatic #ProstateCancer! Progression of…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @ErinGillespieMD: 54 pts with oligomet prostate ca (1-3 lesions: 2/3 node-only, 1/3 bone-only). "Total consolidation of PSMA radiotracer…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @ErinGillespieMD: 54 pts with oligomet prostate ca (1-3 lesions: 2/3 node-only, 1/3 bone-only). "Total consolidation of PSMA radiotracer…
RT @ErinGillespieMD: 54 pts with oligomet prostate ca (1-3 lesions: 2/3 node-only, 1/3 bone-only). "Total consolidation of PSMA radiotracer…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
More evidence in support of radiotherapy for oligometastatic disease. @UCSDRadMed @PCF_Science
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @ErinGillespieMD: 54 pts with oligomet prostate ca (1-3 lesions: 2/3 node-only, 1/3 bone-only). "Total consolidation of PSMA radiotracer…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @ErinGillespieMD: 54 pts with oligomet prostate ca (1-3 lesions: 2/3 node-only, 1/3 bone-only). "Total consolidation of PSMA radiotracer…
RT @ErinGillespieMD: 54 pts with oligomet prostate ca (1-3 lesions: 2/3 node-only, 1/3 bone-only). "Total consolidation of PSMA radiotracer…
RT @SoaresAndrey: Another nice trial looking at metastasis direct SBRT in oligometastatic castration sensitive prostate cancer. Interesting…
Another nice trial looking at metastasis direct SBRT in oligometastatic castration sensitive prostate cancer. Interesting but we must wait for phase 3 data
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @DocGlaser: Nice to see this published!
RT @ErinGillespieMD: 54 pts with oligomet prostate ca (1-3 lesions: 2/3 node-only, 1/3 bone-only). "Total consolidation of PSMA radiotracer…
Great paper on SBRT for OligometPCA
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @ErinGillespieMD: 54 pts with oligomet prostate ca (1-3 lesions: 2/3 node-only, 1/3 bone-only). "Total consolidation of PSMA radiotracer…
RT @ErinGillespieMD: 54 pts with oligomet prostate ca (1-3 lesions: 2/3 node-only, 1/3 bone-only). "Total consolidation of PSMA radiotracer…
54 pts with oligomet prostate ca (1-3 lesions: 2/3 node-only, 1/3 bone-only). "Total consolidation of PSMA radiotracer-avid disease decreased the risk of new lesions at 6 months (16% vs 63%; P = .006)." #pcsm #radonc @TdotJY @CJTsaiMDPhD https://t.co/bRi
The phase II ORIOLE trial is out today! Great work by Phuoc Tran and Ryan Phillips from Johns Hopkins demonstrating the utility of SABR for oligometastatic prostate cancer. Happy to have played a small part! https://t.co/AugXLujMPJ
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @jebibault: After @piet_ost’s STOMP trial, further confirmation that SBRT is relevant in oligometastatic #ProstateCancer! Progression of…
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @jebibault: After @piet_ost’s STOMP trial, further confirmation that SBRT is relevant in oligometastatic #ProstateCancer! Progression of…
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @jebibault: After @piet_ost’s STOMP trial, further confirmation that SBRT is relevant in oligometastatic #ProstateCancer! Progression of…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by Phuoc Tran & team. IMHO confirmation needed on larger trial, active comparator (ADT at least) & more robust endpoint. But a
After @piet_ost’s STOMP trial, further confirmation that SBRT is relevant in oligometastatic #ProstateCancer! Progression of disease at 6 months occurred in 7 of 36 pts (19%) treated with SBRT and in 11 of 18 participants (61%) undergoing observation! #rad
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @SorenBentzen: Phase IIR trial showing highly significant improvement in PFS (HR=0.30; 95% CI, 0.11-0.81; P = .002) after SABR vs. obser…
Phase IIR trial showing highly significant improvement in PFS (HR=0.30; 95% CI, 0.11-0.81; P = .002) after SABR vs. observation in oligometastatic prostate cancer 👉 https://t.co/9bCg1bcJvM. Also, sweet that my colleagues at JHU came up with the backronym -
RT @MartinTomMD: Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer The ORIOLE Phase 2 Randomized Clinical…
Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer The ORIOLE Phase 2 Randomized Clinical Trial #radonc #pcsm https://t.co/byJ2eVL96H https://t.co/s0n2EYDS7t
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @ChristenElledge: So proud of my colleagues at Hopkins! Check out the results of the ORIOLE trail, everyone! #radonc #JohnsHopkins Obs…
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @DocGlaser: Nice to see this published! https://t.co/sbhb0PJuGq
Nice to see this published!
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a systemic immune response https://t.co/YCUF7Dwlfh #VisualAbstract
So proud of my colleagues at Hopkins! Check out the results of the ORIOLE trail, everyone! #radonc #JohnsHopkins Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer https://t.co/VxtqdjyvVw